Voya Investment Management LLC Bristol Myers Squibb CO Transaction History

Voya Investment Management LLC

  • $71.9 Billion
  • Q1 2025

A detailed history of Voya Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Voya Investment Management LLC holds 2,172,440 shares of BMY stock, worth $102 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,172,440
Previous 1,925,677 12.81%
Holding current value
$102 Million
Previous $109 Million 21.65%
% of portfolio
0.18%
Previous 0.14%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$53.9 - $63.11 $13.3 Million - $15.6 Million
246,763 Added 12.81%
2,172,440 $132 Million
Q4 2024

Feb 14, 2025
BUY
$51.92 - $59.94 $49.1 Million - $56.7 Million
946,356 Added 96.63%
1,925,677 $109 Million
Q3 2024

Feb 07, 2025
SELL
$39.66 - $51.75 $10.9 Million - $14.3 Million
-275,623 Reduced 21.96%
979,321 $50.7 Million
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $10.9 Million - $14.3 Million
-275,623 Reduced 21.96%
979,321 $50.7 Million
Q2 2024

Feb 07, 2025
SELL
$40.25 - $52.99 $936,295 - $1.23 Million
-23,262 Reduced 1.82%
1,254,944 $52.1 Million
Q2 2024

Dec 03, 2024
BUY
$40.25 - $52.99 $11.1 Million - $14.6 Million
275,623 Added 28.14%
1,254,944 $52.1 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $936,295 - $1.23 Million
-23,262 Reduced 1.82%
1,254,944 $52.1 Million
Q1 2024

Feb 07, 2025
BUY
$47.98 - $54.4 $14.3 Million - $16.3 Million
298,885 Added 30.52%
1,278,206 $69.3 Million
Q1 2024

Dec 06, 2024
BUY
$47.98 - $54.4 $14.3 Million - $16.3 Million
298,885 Added 30.52%
1,278,206 $69.3 Million
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $2.27 Million - $2.57 Million
-47,319 Reduced 3.57%
1,278,206 $69.3 Million
Q4 2023

Feb 07, 2025
SELL
$48.48 - $57.85 $45.4 Million - $54.1 Million
-935,996 Reduced 41.39%
1,325,525 $68 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $45.4 Million - $54.1 Million
-935,996 Reduced 41.39%
1,325,525 $68 Million
Q3 2023

Feb 07, 2025
BUY
$57.89 - $64.73 $4.29 Million - $4.79 Million
74,027 Added 3.38%
2,261,521 $131 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $4.29 Million - $4.79 Million
74,027 Added 3.38%
2,261,521 $131 Million
Q2 2023

Feb 07, 2025
SELL
$63.71 - $70.74 $17.1 Million - $19 Million
-268,268 Reduced 10.92%
2,187,494 $140 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $17.1 Million - $19 Million
-268,268 Reduced 10.92%
2,187,494 $140 Million
Q1 2023

Feb 07, 2025
BUY
$65.71 - $74.53 $97 Million - $110 Million
1,476,441 Added 150.76%
2,455,762 $170 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $10.5 Million - $12 Million
-160,473 Reduced 6.13%
2,455,762 $170 Million
Q4 2022

Feb 07, 2025
SELL
$68.48 - $81.09 $2.68 Million - $3.17 Million
-39,139 Reduced 1.47%
2,616,235 $188 Million
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $2.68 Million - $3.17 Million
-39,139 Reduced 1.47%
2,616,235 $188 Million
Q3 2022

Feb 07, 2025
BUY
$0.13 - $76.84 $217,886 - $129 Million
1,676,053 Added 171.14%
2,655,374 $189 Million
Q3 2022

Mar 03, 2023
BUY
$0.13 - $76.84 $5,088 - $3.01 Million
39,139 Added 1.5%
2,655,374 $189 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $16,129 - $9.53 Million
124,071 Added 4.9%
2,655,374 $189 Million
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $5.29 Million - $5.83 Million
-72,847 Reduced 2.8%
2,531,303 $195 Million
Q1 2022

May 16, 2022
BUY
$61.48 - $73.72 $3.34 Million - $4.01 Million
54,378 Added 2.13%
2,604,150 $190 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $81,195 - $94,655
-1,514 Reduced 0.06%
2,549,772 $159 Million
Q3 2021

Nov 15, 2021
SELL
$59.17 - $69.31 $3.48 Million - $4.08 Million
-58,897 Reduced 2.26%
2,551,286 $151 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $70.4 Million - $76.7 Million
1,137,860 Added 77.28%
2,610,183 $174 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $97.9 Million - $110 Million
-1,650,125 Reduced 52.85%
1,472,323 $92.9 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $6.74 Million - $7.63 Million
116,686 Added 3.88%
3,122,448 $194 Million
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $2.84 Million - $3.15 Million
-49,481 Reduced 1.62%
3,005,762 $181 Million
Q2 2020

Aug 14, 2020
BUY
$54.82 - $64.09 $941,862 - $1.1 Million
17,181 Added 0.57%
3,055,243 $180 Million
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $19.1 Million - $27.8 Million
412,312 Added 15.7%
3,038,062 $169 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $72 Million - $93.9 Million
1,463,423 Added 125.9%
2,625,750 $169 Million
Q3 2019

Nov 14, 2019
SELL
$42.77 - $50.71 $494,635 - $586,461
-11,565 Reduced 0.99%
1,162,327 $58.9 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $8.04 Million - $8.89 Million
180,185 Added 18.13%
1,173,892 $53.2 Million
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $1.05 Million - $1.25 Million
23,181 Added 2.39%
993,707 $47.4 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $3.07 Million - $3.98 Million
-62,942 Reduced 6.09%
970,526 $50.4 Million
Q3 2018

Nov 14, 2018
SELL
$55.19 - $62.25 $1.6 Million - $1.8 Million
-28,917 Reduced 2.72%
1,033,468 $64.2 Million
Q2 2018

Aug 14, 2018
BUY
$50.53 - $62.98 $13.8 Million - $17.3 Million
274,035 Added 34.76%
1,062,385 $58.8 Million
Q1 2018

May 15, 2018
BUY
$59.92 - $68.98 $1.47 Million - $1.69 Million
24,476 Added 3.2%
788,350 $49.9 Million
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $968,150 - $1.06 Million
-16,152 Reduced 2.07%
763,874 $46.8 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $43.1 Million - $49.7 Million
780,026
780,026 $49.7 Million

Others Institutions Holding BMY

# of Institutions
2,801
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email